Shadi Esfahanai

Professor of Radiology, Director of Molecular Theranostics Laboratory Harvard Medical School

Shadi A. Esfahani, MD, MPH, is a nuclear medicine physician and radiologist at Mass General Brigham. She serves as Director of Theranostics Clinical Trials, overseeing a large portfolio of early- to late-phase imaging and therapeutic radiopharmaceutical clinical trials. As Director of the Molecular Theranostics Laboratory, her research focuses on benchside development and clinical translation of novel radiopharmaceuticals to advance precision cancer care.

Seminars

Wednesday 24th February 2027
Closing the Research-to-Clinic Gap: Building the Evidence to Translate an Academic Target into RLT Development
11:30 am
  • Validating promising academic biology in increasingly translational models to establish whether the target is robust enough for drug development
  • Identifying the critical experiments that increased or challenged confidence to determine when continued investment was justified
  • Bridging academic discovery & industry validation requirements to build an evidence package capable of progressing a novel target towards the clinic

Novel Target

Shadi Esfahani, Speaker at 3rd TRP Target Selection & Drug Design Summit